Two Sigma Investments, LP Bio N Tech Se Put Options Transaction History

Two Sigma Investments, LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $4.39 Million - $8.07 Million	-34,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $2.86 Million - $4.79 Million	13,200 Added 61.11%	34,800 $8.97 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $1.5 Million - $3.26 Million	7,300 Added 51.05%	21,600 $5.9 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $1.62 Million - $3.45 Million	14,300 New	14,300 $3.2 Million

356

38.4M

2.12M

2.17M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.